Matias Molina

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

A Modified Technique of Four-Bone Fusion for Advanced Carpal Collapse (Slac/Snac Wrist)

A. García‐López, María José Pérez-Úbeda, Fernando Marco et al. · Journal of Hand Surgery (European Volume) · 2001 · 32 citations

Hand Trauma, Bone Fusion, Modified Technique +14

Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies.

R. Rosell, Matias Molina, Camila Mendes Costa et al. · Journal of Clinical Oncology · 2010 · 14 citations

High Brca1, Intermediate Brca1, Pretreatment Biopsies +15